[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Menstruation and menopause

Menstruation and menopause can be problematic for all women, but for those with Parkinson’s they may present additional challenges. Unfortunately this is an area that has received little recognition in the past although far more attention is now being paid to this important subject and research is under way to evaluate treatments.

 

Menstruation

It has been suggested that as many as 11 out of 12 pre-menopausal women with Parkinson’s experience a worsening of their symptoms and reduced effectiveness of their medications a few days before (Premenstrual Syndrome – PMS) and during menstruation1, particularly tremor, dyskinesia and rigidity.

Treating PMS is generally the first line of approach but you may find it helpful to discuss this with your neurologist too as in some cases it seems that taking additional Parkinson’s medications during this part of the monthly cycle can help.

Moreover research has revealed that many women suffer increased menstruation problems following the onset of Parkinson’s, in particular more bleeding and associated pain. Women have also expressed concern regarding their changing body image; some felt unattractive and changed their dressing style to cope better with their symptoms, and others described feeling a sense of loss1.

Using sanitary products can be particularly difficult if your symptoms are not well controlled. You may find it helpful to time it so that you change them when you are ‘on’ and have good control.

If menstrual problems are severe then medication such as Danazol can be used to suppress ovulation, although there are possible side effects such as sweating and worsening of Parkinson’s symptoms.

Medication does not always help and if problems are severe then the following options might be available to you:

  • hormone therapy using a combination of oestrogen and progesterone to suppress ovulation
  • surgery, including removal of the lining of the womb or hysterectomy
  • radiotherapy of the ovaries to induce a premature menopause.

These can all have side effects - hot flushes, for example - but women are all affected differently so what works for one person may or may not work for another.

 

Menopause

Menopause can affect sexual desire and function in every woman and quite often these changes occur around the time that Parkinson’s is diagnosed. For some, menopausal symptoms such as sweating can exacerbate symptoms so it might be necessary to involve a gynaecologist or other women’s health professional. There can also be confusion between the symptoms of menopause and Parkinson’s – fatigue, depression and increased sweating for example can occur in both conditions.

As with menstrual problems, Hormone Replacement Therapy (HRT) can be helpful in some cases although research and evidence into its use in Parkinson’s is rather limited. Again, you may need to involve a gynaecologist or other women’s health professional and make sure that they liaise with your specialist so that both conditions are treated effectively.

If you experience vaginal dryness, which is a common sign of menopause, ask your doctor about the use of a vaginal HRT as this may be more helpful than an ordinary lubricant.


Did you know?

According to cross sectional studies, the average age of women starting the menopause is between 50 and 52. Throughout history there has been little or no change to this (the first reference to age at menopause was recorded by the Greeks) with minimal differences between races, irrespective of social status and dietary habits.

  1. Menstrual related fluctuations in Parkinson’s Disease – N Quinn, D Marsden, Movement Disorders 1986; 1:85-92
EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA